LEDERMAN SETH

PrivateCIK: 1563420
Location

NEW YORK, NY

LEDERMAN SETH (Chief Executive Officer) purchased 6779.7% of their position (12K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market

Open‑market purchase worth $7.3K — a major conviction buy. The strongest form of insider conviction signal.

P · 1 purchase
InsiderLEDERMAN SETHCIK 1563420
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+12K
Net shares
Net buyer
$7.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12K acquired
Non-Derivative Transactions1

Common Stock, $0.001 par value

Direct
P · Purchase

Shares

+12K

Price / share

$0.61

Trade value

$7.32K

% of position

6779.7%
9/28/2021
177.0012.18K
Total

Net shares

+12K

Net value

$7.32K

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)8

Common Stock, $0.001 par value

Indirect
Shares owned33.00

Common Stock, $0.001 par value

Indirect
Shares owned59.00

Common Stock, $0.001 par value

Indirect
Shares owned135K

Common Stock, $0.001 par value

Indirect
Shares owned31.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00

Common Stock, $0.001 par value

Indirect
Shares owned205.00

Common Stock, $0.001 par value

Indirect
Shares owned459.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00
Total
135.85K indirect135.85K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
LEDERMAN SETH — Insider Transaction (Form 4) Filed Sep 28, 2021 | Finecho